Utah Medical Products reported a strong first quarter in 2022, with a 12.4% increase in revenues, a 16.3% increase in operating income, and a 16.9% increase in net income compared to the first quarter of 2021. The company's EPS also increased by 16.6%.
Revenues increased by 12.4% compared to Q1 2021.
Operating income increased by 16.3% compared to Q1 2021.
Net income increased by 16.9% compared to Q1 2021.
Earnings per share increased by 16.6% compared to Q1 2021.
Management believes that the 1Q 2022 operating performance provides a start that is consistent with achieving its financial objectives for the calendar year 2022, as previously provided in its 2021 SEC 10-K Report.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance